Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Warnke C, Stettner M, Lehmensiek V, Dehmel T, Mausberg AK, von Geldern G, Gold R, Kümpfel T, Hohlfeld R, Mäurer M, Stangel M, Straeten V, Limmroth V, Weber T, Kleinschnitz C, Wattjes MP, Svenningsson A, Olsson T, Hartung HP, Hermsen D, Tumani H, Adams O, Kieseier BC. Warnke C, et al. Among authors: von geldern g. Mult Scler. 2015 Jul;21(8):1036-44. doi: 10.1177/1352458514556296. Epub 2014 Nov 12. Mult Scler. 2015. PMID: 25392339
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.
Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, Hermsen D, Kleinschnitz C, Hartung HP, Wattjes MP, Svenningson A, Major E, Olsson T, Kieseier BC, Adams O. Warnke C, et al. Among authors: von geldern g. Ann Neurol. 2014 Dec;76(6):792-801. doi: 10.1002/ana.24153. Epub 2014 May 8. Ann Neurol. 2014. PMID: 24729444 Free PMC article.
A 32-year-old man with relapsing-progressive brainstem symptoms.
Lehmann HC, Hengge UR, Alswede L, Saleh A, von Geldern G, Hartung HP, Ruzicka T, Hemmer B. Lehmann HC, et al. Among authors: von geldern g. Lancet Neurol. 2006 Jan;5(1):97-102. doi: 10.1016/S1474-4422(05)70287-8. Lancet Neurol. 2006. PMID: 16361027 No abstract available.
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy.
Stüve O, Cravens PD, Frohman EM, Phillips JT, Remington GM, von Geldern G, Cepok S, Singh MP, Tervaert JW, De Baets M, MacManus D, Miller DH, Radü EW, Cameron EM, Monson NL, Zhang S, Kim R, Hemmer B, Racke MK. Stüve O, et al. Among authors: von geldern g. Neurology. 2009 Feb 3;72(5):396-401. doi: 10.1212/01.wnl.0000327341.89587.76. Epub 2008 Nov 5. Neurology. 2009. PMID: 18987352 Free PMC article. Clinical Trial.
Anosmia as the initial presentation of neurosarcoidosis.
Arcot Jayagopal L, von Geldern G. Arcot Jayagopal L, et al. Among authors: von geldern g. Neurology. 2018 Nov 27;91(22):1020-1021. doi: 10.1212/WNL.0000000000006582. Neurology. 2018. PMID: 30478068 No abstract available.
PML-IRIS in a patient treated with brentuximab.
von Geldern G, Pardo CA, Calabresi PA, Newsome SD. von Geldern G, et al. Neurology. 2012 Nov 13;79(20):2075-7. doi: 10.1212/WNL.0b013e3182749f17. Epub 2012 Oct 31. Neurology. 2012. PMID: 23115213 Free PMC article.
33 results